Losartan reduced strokes and new-onset diabetes more than atenolol in essential hypertension
- Losartan and the meaning of LIFE. Lip, G.Y.H. // Journal of Human Hypertension;May2002, Vol. 16 Issue 5, p289
Explores the treatment of hypertension with the use of losartan. Percentage reduction in the incidence of stroke; Reduction in cases of diabetes in patients treated with losartan; Mechanisms leading to the beneficial effects of losartan; Regression of left ventricular hypertrophy.
- Hypertension, Diabetes Are Clues. Dunbar, Mark T. // Review of Optometry;5/15/2010, Vol. 147 Issue 5, p93
The article discusses the effect of hypertension and diabetes which leads to the progressive vision loss of one's right eye. It mentions that macroaneurysm (MA) is commonly seen in older individuals and is more likely to be observed in females than in males. It cites some systemic risk factors...
- Community Surveillance of Stroke in Persons under 70 Years Old: Contribution of Uncontrolled Hypertension. Barker, William H.; Feldt, Karen S.; Feibel, John H. // American Journal of Public Health;Mar1983, Vol. 73 Issue 3, p260
Abstract: In 1979, a community-wide hospital surveillance system was established in Monroe County, New York (population 702,000), to investigate the continuing contribution of uncontrolled high blood pressure (HBP) to the occurrence o[ stroke. This paper reports findings among 200 consecutive...
- Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Llewellyn, David J.; Lang, Iain A.; Matthews, Fiona E.; Plassman, Brenda L.; Rogers, Mary A. M.; Morgenstern, Lewis B.; Fisher, Gwenith G.; Kabeto, Mohammed U.; Langa, Kenneth M. // Alzheimer's Research & Therapy;2010, Vol. 2 Issue 3, p1
Introduction: Evidence from clinical samples and geographically limited population studies suggests that vascular health, diabetes and apolipoprotein Ïµ4 (APOE) are associated with dementia. Methods: A population-based sample of 856 individuals aged 71 years or older from all contiguous...
- Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. Sander, Dirk; Kearney, Mark T. // Journal of Neurology;Oct2009, Vol. 256 Issue 10, p1603
Reducing the excess cerebrovascular burden in patients with type 2 diabetes remains a major therapeutic challenge, especially with respect to the high risk of recurrent events. Targeting the traditional metabolic risk factors of hypertension, dyslipidemia, and hyperglycemia has failed to remove...
- High BP remains risk factor for diabetes patients. // Drug Topics;10/6/2003 Supplement, Vol. 147 Issue 19, p4s
Reports on the results of a survey conducted by the American Diabetes Association on the risk of heart disease and stroke among diabetes patients with high blood pressure.
- Untitled. // Men's Fitness;Feb2005, Vol. 21 Issue 1, p33
Highlights a Northwestern University study which reported that regular workouts may help reduce risk for heart diseases, high blood pressure, stroke and diabetes.
- New Perspectives on the Pharmacotherapy of Ischemic Stroke. Bradberry, J. Chris; Fagan, Susan C.; Gray, David R.; Moon, Yong S. K. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004 Supplement 1, Vol. 44, pS46
Objective: To provide an overview of the impact of ischemic stroke and the steps that can be taken to reduce its burden through greater awareness of the disease, improved diagnosis and better treatment, with emphasis on the use of antiplatelet agents. Data Sources: Recent (1995-2003) published...
- Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients. Derosa, G; Cicero, A F G; Mugellini, A; Ciccarelli, L; Fogari, R // Journal of Human Hypertension;Jun2003, Vol. 17 Issue 6, p433
Cardiovascular and cerebrovascular disease risks are almost doubled when the hypertensive patient is also affected by diabetes mellitus. Lowering of blood pressure markedly decreases the rate of cardiovascular events and renal deterioration in these patients. The aim of this study is to compare...